Asthma drug may shield hearts of breast cancer patients during chemo
NCT ID NCT05959889
First seen Mar 10, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tested whether montelukast, a drug used for asthma, can reduce heart damage caused by the chemotherapy drug doxorubicin in breast cancer patients. Fifty adults with breast cancer were randomly assigned to receive either montelukast or a placebo alongside their chemotherapy. Researchers measured levels of two heart-related markers in the blood before and after treatment to see if montelukast offered protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damanhour Oncology Center
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.